Literature DB >> 1805555

Effect of physiological and pathological aging processes on topographic bit-mapped cognitive evoked potentials in presenile subjects.

R Zappoli1, A Versari, G Arnetoli, M Paganini, G C Muscas, M G Arneodo, P F Gangemi, M Bartelli.   

Abstract

Bit-mapped multicomponent CNV complex and reaction time (RT) were recorded and measured in 24 presenile patients with initial symptoms of very mild to moderately severe primary mental deterioration without depression, and in 10 age-matched controls. All patients underwent CT and MRI examinations, EEG spectral analysis and a battery of psychometric test. Significant group differences were obtained for measures of some post-S1 ERP and CNV components, particularly of the post-S1 N1b, P300 and early and late pre-S2 CNV. P300 with increased latency, no significant CNV activity, very prolonged RTs, EEG slowing down and diffuse brain atrophy were observed in the majority of patients with probable presenile Alzheimer's dementia. These results suggest that CNV/RT and EEG activity changes similar to those observed in our patients may constitute a valuable clue for the study of brain dysfunction in the early stage of presenile idiopathic cognitive impairment.

Entities:  

Mesh:

Year:  1991        PMID: 1805555

Source DB:  PubMed          Journal:  Acta Neurol (Napoli)        ISSN: 0001-6276


  2 in total

1.  Limited potential for bird migration to disperse plants to cooler latitudes.

Authors:  Juan P González-Varo; Beatriz Rumeu; Jörg Albrecht; Juan M Arroyo; Rafael S Bueno; Tamara Burgos; Luís P da Silva; Gema Escribano-Ávila; Nina Farwig; Daniel García; Ruben H Heleno; Juan C Illera; Pedro Jordano; Przemysław Kurek; Benno I Simmons; Emilio Virgós; William J Sutherland; Anna Traveset
Journal:  Nature       Date:  2021-06-23       Impact factor: 49.962

2.  Neurocognitive and Behavioral Indexes for Identifying the Amnestic Subtypes of Mild Cognitive Impairment.

Authors:  Susana Cid-Fernández; Mónica Lindín; Fernando Díaz
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.